Skip to main content

Advertisement

SpringerLink
Log in

Genetic testing and Alzheimer disease: Has the time come?

  • Commentary
  • Published:

From Nature Medicine

View current issue Submit your manuscript

With the identification of several Alzheimer disease (AD)-associated genes, genetic testing for AD is possible. However, as for some other-late onset disorders, the ethical and social implications of such tests are considerable. In response to the commercial availability and the likely increased use of AD genetic tests, The Stanford Program in Genomics, Ethics, and Society formed a broad-based working group to examine the pros and cons of testing. Here they present their recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Butler, R.N. ApoE: new risk factor for Alzheimer's [editorial]. Geriatrics 49 10–11 (1994).

    PubMed  Google Scholar 

  2. American College of Medical Genetics, American Society of Human Genetics & Working Group on ApoE and Alzheimer Disease. Statement on use of apolipoprotein E testing for Alzheimer disease. J. Am. Med. Assoc. 274, 1627–1629 (1995).

  3. Medical and Scientific Advisory Committee & Alzheimer's Disease International. Consensus statement on predictive testing for Alzheimer disease. Alzheimer Dis Assoc. Disord. 9, 182–187 (1996).

  4. National Institute on Aging & Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 347, 1091–1095 (1996).

  5. Post, S.G. et al. The clinical introduction of genetic testing for Alzheimer disease: an ethical perspective. J. Am. Med. Assoc. 227, 832–836 (1997).

    Article  Google Scholar 

  6. Holtzman, N.A. & Hilgartner, S. Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing. (eds Holtzman, N.A. & Watson, M.S.) (National Institutes of Health, Washington, DC, 1997).

    Google Scholar 

  7. Koenig, B. et al. Genetic testing for BRCA1 and BRCA2: Recommendations of the Stanford Program in Genomics, Ethics, and Society. J. Womens Health 7, 531–545 (1998).

    Article  CAS  Google Scholar 

  8. Lehrman, S. Genetic testing for Alzheimer's disease ‘not appropriate’. Nature 389, 898 (1997).

    Article  CAS  Google Scholar 

  9. Schofield, P.W. et al. Alzheimer's disease after remote head injury: an incidence study. J. Neurol. Neurosurg. Psychiatry 62, 119–124 (1997).

    Article  CAS  Google Scholar 

  10. Farrer, L.A. Genetics and the dementia patient. Neurologist 3, 13–30 (1997).

    Article  Google Scholar 

  11. International Huntington Association & World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 44, 1533–1536 (1994).

  12. Roses, A.D. Apolipoprotein E and Alzheimer's disease: a rapidly expanding field with medical and epidemiological consequences. Ann. NYAcad. Sci. 802, 50–57 (1996).

    Article  CAS  Google Scholar 

  13. Mayeux, R. Saunders, A.M. Shea, S. Mirra, S. & et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N. Engl. J. Med. 338, 506–511 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. L.M. McConnell: Correspondence should be addressed to L.M. e-mail: lauramcc@leland.stanford.edu

Authors and Affiliations

  1. Stanford University Program in Genomics, Ethics, and Society, 701 Welch Road, Suite 1105, Palo Alto, California, 94304, USA

    L.M. McConnell, B.A. Koenig, H.T. Greely & T.A. Raffin

Authors
  1. L.M. McConnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B.A. Koenig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H.T. Greely
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T.A. Raffin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McConnell, L., Koenig, B., Greely, H. et al. Genetic testing and Alzheimer disease: Has the time come?. Nat Med 4, 757–759 (1998). https://doi.org/10.1038/nm0798-757

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0798-757

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation